A survey was done to compare the rates at which phlebitis and extravasation cause failure of intravenous infusions lasting more than 24 hours. Slightly more infusions failed due to phlebitis than to extravasation but extravasation did not occur earlier or later than phlebitis or differ significantly from it in frequency when different types of infusions were compared. Univariate life table analysis indicated that the co-infusion of blood, potassium or cephalosporin antibiotics slightly increased and that higher flow rates markedly increased failure, that infusions including continuous heparin and steroids had markedly decreased failure, and that failure was not significantly affected by other antibiotics or by differences in sex, age, location of infusion site or time of year. Multivariate analysis showed that the above differences were statistically significant only for infusion rate, heparin and steroids.
Patients in hospitals are frequently given intravenous fluids by infusion. Many infusions fail before the intended fluid volume can be given, often because the vein develops phlebitis. Extravasation of infusate is the second most common cause of infusion failure. Much has been written about phlebitis 1 but relatively little is known about extravasation. The signs of extravasation are consistent with the needle or cannula pulling out of the vein and this is usually believed to be its cause. We have proposed that the aetiology of extravasation is usually similar to that of phlebitis with both being initiated by venospasm brought about by infused fluids irritating the endothelium. 2 We believe that the factor which determines whether phlebitis or extravasation ensues is the degree of venoconstriction produced as incomplete occlusion of the vein is likely to lead to phlebitis and complete occlusion to extravasation. If this theory is correct, then types of infusions associated with greater incidences of phlebitis should also have greater incidences of extravasation and the ratio of extravasation to phlebitis should be constant. This survey was therefore done to compare failure of infusions due to extravasation and phlebitis to see if there was a tendency for one to occur before the other or for one to predominate in certain types of infusions.
METHODS
Data including the location of infusion sites, solutions and drugs infused and signs of extravasation and phlebitis were collected during six periods of five to seven days from patients receiving infusions into peripheral veins. Two hundred and fifty-nine infusions were examined. Extravasation was defined as perivenous accumulation of infusate which developed relatively rapidly and then subsided a few hours after the infusion was stopped. Phlebitis was diagnosed from the absence of such rapidly developing swelling and the presence of any two of the following: erythema, tenderness or pain, locally increased temperature and presence of a palpable venous cord. The twenty-two infusions which extravasated with obvious phlebitic signs were excluded from calculations of frequencies of extravasation and phlebitis. All infusions which developed signs of phlebitis and/or extravasation were classed as 'failed infusions' even though they may have been ceased electively.
No data were collected on the type or size of intravenous device as they were often covered with adhesive plaster and could not be seen. At the last inspection in each period, continuing infusions which showed no signs of failure were assumed for statistical purposes to have finished at that time. Resited infusions were treated as new infusions. Data from infusions lasting for less than twentyfour hours were not used as some could have been missed. Some data such as age were not recorded for a few infusions.
Some drugs such as potassium, heparin, steroids and aminophylline, were added to half-or one-litre bags of fluids and infused continuously. Most sites used for bolus doses of drugs were kept open with saline or dextrose infusions rather than being flushed and capped after each use. If continuous infusion ceased and the cannula was capped for bolus injection of drugs, the infusion was considered to have stopped.
The multifactorial aetiology of infusion failure is a problem with analysis of data such as these as it complicates the indentification of individual factors. One important factor which must be taken into account is duration of infusion as all infusions will eventually fail unless ended electively. For this reason, survival analysis was used. Univariate differences in survival between groups were detected by life table (product limit) survival analysis with the significance of differences between infusions with and without factors determined by the log rank test. 3 This method generates the statistic, 'Relative Failure Rate', which is an estimate of relative failure for sets of data (values of less than 1 and of greater than 1 indicate decreased and increased failure respectively). For paired comparisons, the ratio of the two relative failure rates (Odds Ratio) is presented. Multivariate survival analysis to confirm univariate findings was done stepwise with Cox's Proportional Hazards model (Cox model, BMDP statistical package) using MPLR selection and default values.
It is possible that certain factors might influence either the ratio of extravasation to phlebitis or else cause extravasation to occur earlier or later than phlebitis. Differences in the ratio of extravasation to phlebitis were tested by contingency table analysis (X 2 test). Tests for any tendency for either extravasation or phlebitis to occur earlier were done by life table analysis by excluding electively ended infusions and comparing infusions which failed due to phlebitis with those that failed due to extravasation. 3 
RESULTS
Approximately half (53%) of the 259 infusions extravasated or developed phlebitis. Of these, 62 (45%) were phlebitic, 53 (38%) extravasated while 23 (16%) showed obvious signs of both (Table 1) .
Failure of infusions
The overall failure curve was approximately linear from 1 to 4 days with lower failure thereafter ( Figure 1 ). Median survival was 74 hours. Table 1 shows the statistics for the main additives. Antibiotics, individually or collectively, were not associated with significantly altered failure although there was a trend which did not reach statistical significance for increased failure for infusions When the average flow rate was calculated by dividing the total volume infused by the duration of each infusion, there was a highly significant difference in failure when data were divided into high, medium and low flow rate infusions (Table 2) . This difference was smaller but still present when infusions with potassium, heparin and/or steroids were excluded to provide more homogeneous 53.0 74.5 0.96 50.0 76.0 1.05 0.29"' groups. Flow rate was the most significant factor in the multivariate analysis. Differences in failure between sexes, between left and right arms and between the hand, wrist and forearm were not significant ( Table 2) . When data were divided on the basis of age into three groups containing approximately equal numbers, differences were not significant. There was a non- significant trend for increased failure between the first and sixth data collection period by univariate analysis. One factor associated with a significant difference was medical/ surgical diagnosis (Odds ratio 1.71) with greater failure in surgical patients but this disappeared when heparin and/or steroid infusions were excluded.
Extravasation/Phlebitis ratio Each grouping of data in Tables 1 and 2 was tested by univariate analysis to determine if the ratio of extravasation to phlebitis differed. The only analysis in which the probability of a significant difference was greater than P < 0.05 was with the combined data for flow rate where there was approximately twice as much phlebitis as extravasation in the low flow rate group, approximately twice as much extravasation as phlebitis in the medium flow rate group and similar numbers of each in the high flow rate group (X 2 = 8.33; P < 0.02).
U nivariate analysis showed no difference between infusions failing due to extravasation and those failing due to phlebitis (Figure 4) indicating no tendency for one to occur before the other (X 2 = 0.02; Odds ratio 1.03).
DISCUSSION
Most papers on failure of intravenous infusions have used criteria for ranking the severity of phlebitis based on the range and extent of phlebitic signs. 4 -6 Such criteria ignore extravasation and can be difficult to use as some phlebitic signs may not appear or do not appear in the expected order. Also, assessors usually are consistent in diagnosing phlebitis but there can be differences in their interpretation of phlebitic signs. 7 ,8 Degree of severity is an unimportant factor as it depends on how closely infusions are supervised as the severity of phlebitic signs will increase with time until an infusion is stopped. As schemes based on differences in severity are unsuitable for survival analysis, the simpler criterion was adopted of considering an infusion to have failed if it showed phlebitic and/or extravasation signs.
The wide range in duration of infusions causes problems in analysing data such as these. Infusions in this survey of less than 24 hours were excluded but Figure 1 indicates that the percentage of surviving infusions decreased after this time until 72 hours in a linear manner with time. The flattening of the curve after this was largely because most infusions lasting longer than 72 hours included heparin.
Another problem is that many infusions are stopped electively. Most previous surveys have been analysed either by the X2 test on proportions of infusions showing phlebitic signs at successive 12-or 24-hour intervals or by 't' tests on mean times to failure with electively-ended infusions usually being ignored. These methods lead to loss of information 3 and survival analysis which others have used for similar data lO -12 is preferable.
It is commonly believed that antibiotics cause infusions to fail. The univariate result for the cephalosporin group is compatible with the findings of others that these early cephalosporin increase failure l3 ,14 but the multivariate analysis provided no evidence for any antibiotic affecting failure.
Several papers have reported that heparin and/or steroids decrease failure of infusions. 15 -18 These additives were mainly responsible for the difference between surgical and medical patients as their use was largely confined to medical patients.
Potassium increased failure in other studies.9.19-21 It was added only to some bags of fluids given to patients and several reported pain at the infusion site which was only present or was much greater when receiving fluid with added potassium, indicating that it was irritant. Additions were usually done in the ward and it is possible that incomplete mixing may have been a factor,22 especially as more recent observations of infusions with premixed potassium did not show this effect (J. F. Hecker, unpublished). Univariate but not multivariate analysis identified potassium and so the situation is unclear regarding its irritancy in this survey.
The absence of highly significant differences due to 'drugs' indicates that crystalloid solutions are the main cause of vein irritation which leads to failure. The common crystalloid fluids are mildly acid 23 and neutralisation markedly reduces failure of infusions. 8, 24, 25 We have shown that local transcutaneous glyceryl tnnltrate substantially decreases failure of intravenous infusions,12 probably because increased local blood flow neutralises the acidity.
It follows that higher infusion rates have less dilution with blood and so will cause greater irritation of the vein and will increase the likelihood of infusion failure. The highly significantly increased failure with the high flow rates support this theory. Rate could be involved in some differences in Tables 1 and 2, for example the cephalosporin antibiotic infusions which had increased failure by univariate analysis had higher average flow rates. Also there appear to be negative associations between the mean flow rate and the Odds ratio for the individual antibiotics and for the other additives in Table 1 and for Series in Table 2 . Part of the decreased failure with heparin and steroids could have been because they were given at relatively low flow rates. The advantage of the multifactorial analysis is that it allows for such interactions.
The survey permitted detection of possible seasonal effects as the first two periods were in winter, the next two in spring and the last two in summer. Wards were not air-conditioned and were much warmer in the last two than in the first two periods. Warm weather might be expected to induce greater blood flow in superficial veins, producing greater dilution of infusate by blood and so decreasing failure, but there was actually a tendency for increased failure during warmer weather shown by univariate analysis. It was noticed that superficial veins were rarely obvious on the contralateral arms of patients even on the warmest days of periods 5 and 6 although the arm veins of staff were usually dilated.
The aim of the survey was to investigate extravasation in relation to phlebitis. In sixteen comparisons of additives and in eight comparisons of factors such as sites and ages, the ratio of extravasation to phlebitis differed significantly only for flow rate. This flow rate significant difference probably can be discounted as statistical theory predicts that multiple comparisons as done here increase the likelihood of false significant results (1 in 20 comparisons can be expected to provide a probability value of < 0.05 by chance even when the difference is not real).
There was also no tendency for either cause of failure to precede the other. This lack of difference between extravasation and phlebitis would therefore support our contention 2 that extravasation is usually initiated by phlebitic processes.
